Navigation Links
Pharma and food thought leaders set to converge in Amsterdam next April
Date:8/20/2010

Amsterdam, 20 August 2010 - Pharma-Nutrition, the new international scientific conference organised by Elsevier, the leading publisher of scientific, technical and medical information products and services, aims to discuss the latest research, concepts and practical applications of medical nutrition in patient treatments, disease management and patient outcomes. Pharma-Nutrition is set to take place next 18-20 April at Amsterdam's NH Grand Hotel Krasnapolsky. The convergence of both pharmacology and food science professionals, will make this the first platform dedicated to the scientific interface between pharma and food.

The Scientific Committee composed of acknowledged opinion leaders in both food science and pharmacology from across the spectrum of therapeutic research areas will work alongside organisers to develop a multidisciplinary programme, covering areas such as oncology, immunology, neurology and cardiovascular disease. The Conference Chairman, Professor Johan Garssen, University of Utrecht, commented, "We are starting to see a real convergence of the two areas of pharma and food and it is their complementary values which can be applied to medical nutrition in order to help address the ever growing burden of diseases in modern society."

"I am so pleased that we have been able to bring together for the first time such an outstanding group of preclinical and clinical experts from both pharma and nutrition," said Dr. Jaap van Harten, Elsevier Executive Publisher. "This conference will provide the platform for participants to share and discuss their latest research on this important area of science," he remarked.


'/>"/>

Contact: Rachel Martin
r.martin@elsevier.com
31-020-485-2467
Elsevier
Source:Eurekalert

Page: 1

Related biology news :

1. CoLucid Pharmaceuticals, Inc. announces study data documenting oral efficacy of lasmiditan (COL-144), a selective 5-HT1F receptor agonist, in the treatment of acute migraine attacks
2. Pitt pharmacologists go on a molecular fishing trip and hook prize catch
3. ACS Green Chemistry Institute Pharmaceutical Roundtable award goes to Scottish chemist
4. ViroPharma Announces Initiation of Phase 2 Evaluation of Subcutaneous Delivery of Cinryze(TM) (C1 Esterase Inhibitor [Human])
5. Biostar Pharmaceuticals, Inc. Receives New Advertising Approval from Shaanxi SFDA for Marketing Xin Aoxing Capsule
6. URI pharmacy researcher finds beneficial compounds in pure maple syrup
7. NIH awards $8.5 million for research on pharmaceuticals for children
8. TNO and Seventh Wave sign letter of intent on joint preclinical pharmaceutical outsourcing services
9. GREENBioPharma -- Dec. 2-3, 2009
10. ERGONEX Pharma receives Frost & Sullivans European Orphan Diseases Entrepreneurial Company Award 2009
11. TAXIS Pharmaceuticals licenses novel antimicrobial technology from Rutgers and UMDNJ
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/23/2017)... , Aug. 23, 2017  The general public,s help is being ... microbiome—the bacteria that live in and on the human body –and are ... The Microbiome ... the human microbiome, starting with the gut. The project's goal is to ... Photo credit: IBM ...
(Date:8/15/2017)... LLC , a medical device company focused on improving the safety ... ISO 13485 Certification, the global standard for medical device quality management ... ... for the early detection of IV infiltrations. ... "This is an important milestone for ivWatch, as it validates our ...
(Date:7/20/2017)... , July 20, 2017 Delta (NYSE: DAL ... board any Delta aircraft at Reagan Washington National Airport (DCA). ... Delta launches biometrics to ... Delta,s biometric ... Sky Club is now integrated into the boarding process to allow ...
Breaking Biology News(10 mins):
(Date:9/21/2017)... Paramus, New Jersey (PRWEB) , ... September 21, ... ... for highly-regulated pharmaceutical and clinical research sector professionals, has announced the addition of ... CFR Part 11 training - Compliance with Regulation 21 CFR Part 11 ...
(Date:9/21/2017)... ... September 21, 2017 , ... Biorez, ... election of Paul Hermes, Entrepreneur in Residence at Medtronic, Inc., to serve as ... a proprietary, tissue-engineered scaffold for anterior cruciate ligament (ACL) reconstruction that is designed ...
(Date:9/20/2017)... ... 20, 2017 , ... Diversity focused business accelerator, The Refinery , announced ... to uncover the top technology-driven, women-led startups in Boston, MA, New Haven/Hamden, CT, and ... entrepreneurial events going on that week – in Boston, it will be part of ...
(Date:9/20/2017)... East Hanover, N.J. (PRWEB) , ... ... ... Foundation researchers have recently published findings of a study examining the effects ... and individuals with spinal cord injury (SCI). The article, "Neuromechanical adaptations during ...
Breaking Biology Technology: